3T Biosciences
3T Biosciences is a biotechnology company developing immunotherapies.
All edits
Edits on 8 Feb, 2024
Amy Sar
Edits on 19 Dec, 2023
Edits on 29 Nov, 2023
Amy Sar
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-2 properties)
Infobox
Official Website
Official Website
Edits on 5 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Wellfound ID
3t-biosciences
Edits on 6 Apr, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 13 Nov, 2022
Semyon Kolychev
Edits made to:
Infobox (+1 properties)
Infobox
Glassdoor ID
2995177
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 25 Aug, 2022
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Golden AI
Edits made to:
Infobox (+4/-4 properties)
Infobox
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Latest Funding Round Amount (USD)
12,000,000
Olga Shabunina
Edits made to:
Infobox (+1 properties)
Infobox
Funding Rounds
Edits on 28 Jul, 2022
Golden AI
Edits made to:
Timeline
Timeline
October 4, 2017
Their seed funding round raised $12 million in capital from Sean Parker (lead investor), Peter Thiel, Starlight Ventures, OS Fund, Menlo Ventures, CRV, and Asset Management Ventures (AMV).
Golden AI
Edits made to:
Article
Article
On October 4, 2017 3T Biosciences completed their seed funding round with $12 million in capital from Sean Parker (lead investor), Peter Thiel, Starlight Ventures, OS Fund, Menlo Ventures, CRV, and Asset Management Ventures (AMV).
Find more companies like 3T Biosciences
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
